Prices delayed by at least 15 minutes | Print
XOMA Corp (XOMA)
Common SharesThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.
Address
1209 Orange Street
Corporation Trust Center
Wilmington
DE
USA
19801
Telephone
+1 510 204-7200
Forecast key dates
Name | Key Date |
---|---|
XOMA Corp Annual General Meeting for 2025 | 2025-05-15T09:00:00 |
XOMA Corp Fourth Quarter Earnings Results for 2024 | 2025-03-07T00:00:00 |
XOMA Corp Annual Report for 2024 | 2025-03-07T00:00:00 |
XOMA Corp Third Quarter Earnings Results for 2024 | 2024-11-07T00:00:00 |
XOMA Corp Second Quarter Earnings Results for 2024 | 2024-08-08T00:00:00 |
XOMA Corp Annual General Meeting for 2024 | 2024-05-15T09:00:00 |
XOMA Corp First Quarter Earnings Results for 2024 | 2024-05-09T00:00:00 |
Previous key dates
Name | Key Date |
---|---|
XOMA Corp Annual General Meeting for 2024 | 2024-05-15T09:00:00 |
XOMA Corp First Quarter Earnings Results for 2024 | 2024-05-09T00:00:00 |
The Leerink Partners 2024 Global Biopharma Conference | 2024-03-11T10:40:00 |
XOMA Corp Fourth Quarter Earnings Results for 2023 | 2024-03-08T00:00:00 |
XOMA Corp Annual Report for 2023 | 2024-03-08T00:00:00 |
the 44th Annual TD Cowen Health Care Conference 2024 | 2024-03-06T10:30:00 |
XOMA Corp Third Quarter Earnings Results for 2023 | 2023-11-07T00:00:00 |
XOMA Corp Second Quarter Earnings Results for 2023 | 2023-08-08T00:00:00 |
XOMA Corp Annual General Meeting for 2023 | 2023-05-17T09:00:00 |
XOMA Corp First Quarter Earnings Results for 2023 | 2023-05-09T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.